Topical Protease Inhibitor Increases Tumor-Free and Overall Survival in CD4-Depleted Mouse Model of Anal Cancer
Patients with immunodeficiencies and older age are at an increased risk of anal cancer. Transgenic <i>K14E6/E7</i> mice with established high-grade anal dysplasia were treated topically at the anus with the protease inhibitor saquinavir (SQV) in the setting of CD4+ T-cell depletion to mi...
Saved in:
| Main Authors: | Evan Yao, Laura Gunder, Tyra Moyer, Kristina A. Matkowskyj, Kathryn Fox, Yun Zhou, Sakura Haggerty, Hillary Johnson, Nathan Sherer, Evie Carchman |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-09-01
|
| Series: | Viruses |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4915/16/9/1421 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Trends in Mortality of Anal Cancer in Brazil, 2012-2021
by: Camila Rafaela Lazaretti, et al.
Published: (2025-06-01) -
Clinical characteristics and treatment outcome in p16 negative anal cancer
by: Catherine Burgos, et al.
Published: (2025-05-01) -
Anal fistula metastasis of rectal cancer after neoadjuvant therapy: a case report
by: Shota Fukai, et al.
Published: (2022-03-01) -
Anal metastasis of rectal cancer—adenocarcinoma of squamous cells: a case report and literature review
by: Shun Sasaki, et al.
Published: (2017-04-01) -
Anal Incontinence after Anterior Rectum Resection in Cancer Patients
by: O. I. Kit, et al.
Published: (2020-04-01)